Biovigilance Programme of India Approved for Transplants
Why in the news
The government cleared a national programme to watch over the safety of products used in transplant procedures.
Key facts
- Programme: Biovigilance Programme of India, cleared by the government.
- Scope: drugs and biological products employed for organ and tissue transplants.
- Coordinating body: Indian Pharmacopoeia Commission (IPC).
About the programme
- A national patient-safety surveillance effort.
- Handles prevention, monitoring, assessment and reporting of adverse events linked to such products.
Exam angle
- Nodal coordinator: IPC.
- Area: transplantation safety.
- Key term: adverse events.